Tonix Pharmaceuticals Holding Corp. reported preliminary financial results for the year ended December 31, 2025, showing a net loss of approximately $118.9 million and cash resources of $207.6 million as of January 30, 2026; net revenue from product sales was about $13.1 million, compared to $10.1 million in 2024.